VA Reverses PACT Act Breast Cancer Policy
The Department of Veterans Affairs (VA) has reversed its policy on male breast cancer, removing the disease from a list of presumptive conditions for VA treatment and compensation under the PACT Act.
The change means male veterans must now prove their breast cancer diagnosis is service-connected to receive VA disability benefits for the condition.
VA Reverses PACT Act Breast Cancer Policy
The Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics (PACT) Act of 2022 was a large expansion of veteran benefits designed to correct decades of neglect by acknowledging the severe health consequences of toxic exposure from burn pits, Agent Orange, and other hazardous substances.
The law’s most powerful tool is the presumptive condition list, which automatically establishes service connection for diseases related to military service in known areas of toxic exposure.
Before the PACT Act, a veteran had to prove not only that they were sick, but that their sickness was a direct result of military service, a nearly impossible standard that led to countless denials.
According to the Department of Veterans Affairs, the previous inclusion of male breast cancer had “falsely classified male breasts as reproductive organs.”
Politics over Vet Care?
The policy appears to have angered veteran advocates and many members of Congress.
Critics, including the ranking member of the House Veterans’ Affairs Committee, accused the VA of prioritizing a political agenda over the well-being of veterans, arguing that the original 2024 decision to include male breast cancer was based on science.
Critics add that the 2025 reversal lacks new medical evidence.
For a male veteran diagnosed with this disease after September 30, 2025, VA care options have reverted to pre-PACT Act benefits. The patient will not receive automatic coverage for care and disability the way other diseases and conditions listed undert the PACT Act warrant.
The veteran must, while undergoing treatment, begin the process of filing a claim to prove his cancer is “at least as likely as not” related to military service.
VA Policy
The VA’s official stance is that these veterans can still apply for benefits on an individual basis. However, this returns the burden of proof to the individual, a barrier the PACT Act was designed to remove.
In 2024, the VA, using the authority granted by the PACT Act, added male breast cancer to this list. The PACT Act’s text includes “reproductive cancer of any type” as a presumptive condition.
The VA’s scientific and medical experts determined that, given the biological and epidemiological similarities of male and female breast tissue and their shared response to toxins, male breast cancer fit this classification.
The policy change reversing this is troubling. It demonstrates a willingness to reinterpret a landmark law through a narrow, non-scientific lens.
Male breast cancer, while rare, is known to be more common in the veteran population than in the general public, and doctors often diagnose it at later, more aggressive stages.
Making it harder for veterans to get treatment and compensation for illnesses they incurred in the line of duty is not fair to them or their families.
About the author
Editor-in-Chief Joe Wallace is a 13-year veteran of the United States Air Force and a former reporter/editor for Air Force Television News and the Pentagon Channel. His freelance work includes contract work for Motorola, VALoans.com, and Credit Karma. He is co-founder of Dim Art House in Springfield, Illinois, and spends his non-writing time as an abstract painter, independent publisher, and occasional filmmaker.
